BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1493908)

  • 1. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
    Dubosc-Marchenay N; Lacombe F; Dumain P; Marit G; Montastruc M; Belloc F; Reiffers J
    Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
    Willman CL; Stewart CC; Longacre TL; Head DR; Habbersett R; Ziegler SF; Perlmutter RM
    Blood; 1991 Feb; 77(4):726-34. PubMed ID: 1825181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy.
    Campos L; Guyotat D; Archimbaud E; Devaux Y; Treille D; Larese A; Maupas J; Gentilhomme O; Ehrsam A; Fiere D
    Br J Haematol; 1989 Jun; 72(2):161-6. PubMed ID: 2757962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
    Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
    Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia.
    Lanza F; Rigolin GM; Moretti S; Latorraca A; Castoldi G
    Leuk Lymphoma; 1994; 13 Suppl 1():81-5. PubMed ID: 7521238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
    Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig WD
    Blood; 1995 Oct; 86(8):3097-108. PubMed ID: 7579404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia].
    Gu LJ; Tie LJ; Jiang LM; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP; Ye H
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):241-5. PubMed ID: 19374802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.
    Marosi C; Köller U; Koller-Weber E; Schwarzinger I; Schneider B; Jäger U; Vahls P; Nowotny H; Pirc-Danoewinata H; Steger G
    Cancer Genet Cytogenet; 1992 Jul; 61(1):14-25. PubMed ID: 1638477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.
    Dunphy CH; Tang W
    Arch Pathol Lab Med; 2007 May; 131(5):748-54. PubMed ID: 17488160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.